SYSTEMATIC AND SAMPLING MEDIASTINAL LYMPH NODE DISSECTION OF COMBINED TREATMENT OF NON-SMALL CELLS LUNG CANCER IIIA(N2) STAGE

SYSTEMATIC AND SAMPLING MEDIASTINAL LYMPH NODE DISSECTION OF COMBINED TREATMENT OF NON-SMALL CELLS LUNG CANCER IIIA(N2) STAGE

This article  provides  results  of  combined modality  treatment of  patients with  stage IIIA(N2) non-small cells lung cancer  with systematic and selective   lymph node  dissection. Elicit that  the  selective    lymph  node  dissection is valid for  patients with  stage IIIA(N2) squamous cell ca...

Full description

Saved in:
Bibliographic Details
Main Authors: E. O. Mantsyrev, A. V. Vazhenin, O. A. Gladkov, A. A. Lukin, M. N. Mironchenko, Ya. A. Gnatiuk, S. N. Timofeev
Format: Article
Language:English
Published: Bashkir State Medical University 2017-02-01
Series:Креативная хирургия и онкология
Subjects:
non-small cell lung cancer
sampling mediastinal lymph node dissection
systematic mediastinal lymph node dissection
combined treatment
Online Access:https://www.surgonco.ru/jour/article/view/172
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This article  provides  results  of  combined modality  treatment of  patients with  stage IIIA(N2) non-small cells lung cancer  with systematic and selective   lymph node  dissection. Elicit that  the  selective    lymph  node  dissection is valid for  patients with  stage IIIA(N2) squamous cell carcinoma and right-sided lung cancer when we provide combined modality treatment using adjuvant radiation therapy. Carrying out that  the systematic  lymph node dissection is extend   disease-free survival and  five-year survival rate  when  we  provide combined modality  treatment for  patients with  stage IIIA(N2) squamous cell carcinoma and left-sided lung cancer.
ISSN:2076-3093
2307-0501

Similar Items